The 35th CINP World Congress of Neuropsychopharmacology

Presentation information

[CINP2024] Poster Session

CINP2024 » Poster Session

Schizophrenia 1 - Clinical (1)

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

[P130] Celecoxib added to risperidone for depressive symptoms in first-episode and drug naïve schizophrenia: Pharmacogenetic impact of BDNF gene polymorphisms

*Dongmei Wang1,2, Xijing Chen1,2, Yang Tian1,2, Zhixuan Yu1,2, Dachun Chen3, Meihong Xiu3, Thomas Kosten4,5, Xiangyang Zhang1,2 (1. CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China, 2. Department of Psychology, University of Chinese Academy of Sciences, Beijing, China, 3. Beijing HuiLongGuan Hospital, Peking University, Beijing, China, 4. Mental Health Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA, 5. Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, USA)

Keywords:Schizophrenia, Depressive symptom, Cyclooxygenase-2, Celecoxib, BDNF

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

Password